Diagnosis, treatment, response monitoring, and outcome of pediatric acute myeloid
leukemia (AML) have made enormous progress during the past decades. Because AML is a …

Despite major improvements in outcome over the past decades, acute myeloid leukemia
(AML) remains a life-threatening malignancy in children, with current survival rates of∼ …

JCM | Free Full-Text | Pediatric Acute Myeloid Leukemia—Past, Present, and Future Next
Article in Journal Sexual Habits and Sexual Dysfunctions in a Sample of Patients with Psychotic …

Childhood malignancies are rarely related to known environmental exposures, and it has
become increasingly evident that inherited genetic factors play a substantial causal role …

Further incorporation of genomic and molecular data in pediatric AML will allow for
additional refinements in risk stratification to enable the tailoring of treatment intensity. These …

To define the mutation spectrum in non-Down syndrome acute megakaryoblastic leukemia
(non-DS-AMKL), we performed transcriptome sequencing on diagnostic blasts from 14 …

Acute megakaryoblastic leukemia (AMKL) is a subtype of acute myeloid leukemia (AML) in
which cells morphologically resemble abnormal megakaryoblasts. While rare in adults …

Children with constitutional trisomy 21 (Down syndrome (DS)) have a unique predisposition
to develop myeloid leukaemia of Down syndrome (ML-DS). This disorder is preceded by a …

Summary The Medical Research Council Acute Myeloid Leukaemia 12 (MRC AML12) trial
(children) addressed the optimal anthracenedione/anthracycline in induction and the …

Approximately 10% of the neonates with Down syndrome (DS) exhibit a unique transient
leukemia (TL). Though TL resolves spontaneously in most patients, early death and …